Fluicell AB (ST:FLUI) — Market Cap & Net Worth
Market Cap & Net Worth: Fluicell AB (FLUI)
Fluicell AB (ST:FLUI) has a market capitalization of $2.11 Million (Skr19.58 Million) as of May 4, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #29637 globally and #688 in its home market, demonstrating a 7.14% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Fluicell AB's stock price Skr14.25 by its total outstanding shares 1373703 (1.37 Million). Analyse FLUI cash flow conversion to see how efficiently the company converts income to cash.
Fluicell AB Market Cap History: 2018 to 2026
Fluicell AB's market capitalization history from 2018 to 2026. Data shows change from $1.02 Million to $2.11 Million (-0.80% CAGR).
Fluicell AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Fluicell AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Fluicell AB's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $1.02 Million | $1.23 Million | -$14.70 Million | 0.83x | N/A |
| 2019 | $1.29 Million | $2.49 Million | -$18.64 Million | 0.52x | N/A |
| 2020 | $3.02 Million | $4.63 Million | -$18.15 Million | 0.65x | N/A |
| 2021 | $2.97 Million | $2.60 Million | -$21.72 Million | 1.14x | N/A |
| 2022 | $384.36K | $3.25 Million | -$21.49 Million | 0.12x | N/A |
| 2023 | $93.43K | $3.34 Million | -$26.55 Million | 0.03x | N/A |
| 2024 | $6.06K | $1.86 Million | -$15.51 Million | 0.00x | N/A |
Competitor Companies of FLUI by Market Capitalization
Companies near Fluicell AB in the global market cap rankings as of May 4, 2026.
Key companies related to Fluicell AB by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #223 globally with a market cap of $107.56 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $72.88 Billion USD.
- UCB SA (BR:UCB): Ranked #517 globally with a market cap of $51.45 Billion USD ( €44.01 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #568 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #223 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $107.56 Billion | $423.92 |
| #367 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $72.88 Billion | $701.42 |
| #517 | UCB SA | BR:UCB | $51.45 Billion | €231.20 |
| #568 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
Fluicell AB Historical Marketcap From 2018 to 2026
Between 2018 and today, Fluicell AB's market cap moved from $1.02 Million to $ 2.11 Million, with a yearly change of -0.80%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr2.11 Million | +42.50% |
| 2025 | Skr1.48 Million | +24290.24% |
| 2024 | Skr6.06K | -93.51% |
| 2023 | Skr93.43K | -75.69% |
| 2022 | Skr384.36K | -87.06% |
| 2021 | Skr2.97 Million | -1.47% |
| 2020 | Skr3.02 Million | +133.94% |
| 2019 | Skr1.29 Million | +26.40% |
| 2018 | Skr1.02 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Fluicell AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.11 Million USD |
| MoneyControl | $2.11 Million USD |
| MarketWatch | $2.11 Million USD |
| marketcap.company | $2.11 Million USD |
| Reuters | $2.11 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Fluicell AB
Fluicell AB (publ) operates as a life science company, provides platforms and research solutions for bioprinting and single-cell biology. The company offers BIOPEN, a microfluidic platform for high-precision single-cell solution delivery that enables to control the cell microenvironment without moving or disturbing the cells; Biozone 6 that generate dose-response curves or study the effects of mu… Read more